Companies /Basic Materials
Eastman Chemical Company
NYSE: EMN Specialty Chemicals
$65.39
▲ $0.98 (+1.52%) today
Markets closed · 12:11am ET

Eastman Chemical (EMN) Q3 2026 Earnings

Reported Oct 29, 2026, 4:19pm ET · SEC source
$1.84
Miss −4.04%
EPS · est. $1.92 Adjusted

GAAP diluted EPS of $2.19 includes a $39 million interim adjustment to tax provision ($0.35 per share) excluded from adjusted EPS; no other non-core items in the quarter.

$2.4B
Miss −0.80%
Revenue · est. $2.4B
1 quarter
Consecutive EPS misses

How Did EMN Stock React to Q3 2026 Earnings?

% change · around the report
0+3%Oct 29Oct 30report 4:19pm ETearnings−1.3%+1.0%
0+3%Oct 29Oct 30earnings−1.3%+1.0%
EMN +1.0%S&P 500 −1.3%
−3%0+3%Oct 29Oct 30report 4:19pm ETearnings−2.3%+1.0%
−3%0+3%Oct 29Oct 30earnings−2.3%+1.0%
EMN +1.0%NASDAQ −2.3%
−2%0+2%Oct 28Nov 3report 4:19pm ETearnings−1.7%−0.5%
−2%0+2%Oct 28Nov 3earnings−1.7%−0.5%
EMN −0.5%S&P 500 −1.7%
−3%0+3%Oct 28Nov 3report 4:19pm ETearnings−3.6%−0.5%
−3%0+3%Oct 28Nov 3earnings−3.6%−0.5%
EMN −0.5%NASDAQ −3.6%
−2.06%
Day of report
+0.38%
Next session
−3.19%
One week

Did EMN Beat Earnings? Q3 2026 Results

No. Eastman Chemical reported Q3 2026 earnings of $1.84 a share on Oct 29, 2026, missing the $1.92 consensus estimate by 4.0%. Revenue was $2.4B against a $2.4B estimate.

Eastman Chemical posted a disappointing third quarter of 2026, missing on both the top and bottom lines as escalating Middle East conflict drove up raw material and distribution costs faster than the company could recover them through pricing. Adjusted EPS of $1.84 fell short of the $1.92 consensus by 4.04%, while revenue of $2.38 billion trailed the $2.40 billion estimate by 0.80%, even as sales rose 8.3% year over year on the back of 7% higher selling prices and modest volume gains. The clearest bright spot was Advanced Materials, where adjusted EBIT nearly doubled to $103 million from $53 million a year ago on improved asset utilization and lower maintenance costs, though a sequential 5% revenue decline from Q2 reflected seasonal softness and weakening automotive and consumer durables demand. JPMorgan's recent downgrade of the stock to Neutral, citing commodity value concerns, added another layer of caution around the name. Looking ahead, Eastman guided full-year 2026 adjusted EPS of $6.00 to $6.20 and operating cash flow of roughly $850 million, with additional pricing actions planned to counter accelerating costs.

Key Takeaways
  • 7 percent higher selling prices and 1 percent higher sales volume/mix drove 8 percent sales growth
  • Improved asset utilization following Q3 2025 inventory reduction actions, plus lower planned maintenance expense
  • Favorable price-cost; higher variable compensation expense partially offset
  • Advanced Materials adjusted EBIT rose to $103 million from $53 million; margin 13.5% vs 7.3%
  • Additives & Functional Products adjusted EBIT rose to $154 million from $128 million on cost-pass-through pricing
  • Chemical Intermediates adjusted EBIT rose to $35 million from $1 million on higher spreads and tight olefin markets
  • Fibers adjusted EBIT fell to $52 million from $67 million on lower acetate tow contract pricing
  • $39 million interim tax provision benefit lifted GAAP EPS to $2.19

“Eastman delivered solid results amid ongoing global macroeconomic uncertainty and escalation of the Middle East conflict. Input costs continued to elevate, and the Eastman team successfully implemented higher sequential price increases in our specialties. We remain on track to implement approximately $500 million of selling price increases in 2026 compared to our expectations from before the Middle East conflict began.”

Eastman Chemical CEO, on the earnings call

What Is Eastman Chemical's Outlook?

Eastman expects a solid full-year 2026 in both earnings and cash flow despite a challenging macro environment and the escalating Middle East conflict, which has raised raw material and distribution costs and interest rates. It projects full-year 2026 adjusted EPS of $6.00 to $6.20 and operating cash flow of approximately $850 million. For Q4, management expects: - Sequential demand declines from normal seasonality and some customer caution, partly offset by innovation-driven growth. - Higher acetate tow volumes in Fibers as customers meet annual contract commitments. - Additional price actions across the company. - Higher planned shutdown costs, partly offset by continued cost actions. - A release of working capital. Cost savings of $125 million to $150 million, net of inflation, remain on track.

EMN YoY Financials

Q3 2026 vs Q3 2025 · SEC filings Q3 2025 Q3 2026
$0$700.0M$1.4B$2.1B$2.2B$2.4BRevenue$433.0M$532.0MGross Profit$210.0M$305.0MOperating Income$47.0M$252.0MNet Income
$0$700.0M$1.4B$2.1BRevenueGross ProfitOperating IncomeNet Income
EMN income statement, Q3 2026 versus Q3 2025
Metric Q3 2026 Q3 2025 Year over year
Revenue $2.4B $2.2B +8.3%
Gross Profit $532.0M $433.0M +22.9%
Operating Income $305.0M $210.0M +45.2%
Net Income $252.0M $47.0M +436.2%

EMN Revenue by Segment

Advanced Materials$762.0M+5.0%
Additives & Functional Products$784.0M+9.0%
Chemical Intermediates$580.0M+16.0%
Fibers$255.0M+0.0%

EMN Revenue by Geography

North America$1.1B+12.6%
EMEA$609.0M+8.2%
Asia Pacific$535.0M+0.2%
Latin America$147.0M+10.5%

When Does Eastman Chemical Report Next?

Expected report date
After the close
Release timing

Figures from SEC filings and company reports. Not investment advice.